The Eastern High Court finds that Huawei and Sony infringe Sonion's patent and utility model rights, upholding the preliminary injunction granted by the Maritime and Commercial High Court.

The use of AI systems and chatbots by employees and employers is gaining more and more foothold at workplaces.

On 4 April 2025, the Eastern High Court ruled in favour of Plesner, finding that two board members were entitled to tax deductions...

The latest economic sanctions and individual restrictive measures aim to limit Russia's access to military technology and reduce its energy revenues.

A new extensive Act on Mineral Activities was adopted by the Greenland Parliament on 31 May 2023 - issues remain unclear regarding market needs and industry demands.

The Danish Board for Health Apps has recently established the criteria for evaluating and recommending health apps, and an application form is now ready for use.

The ICH has adopted its revised Guideline for Good Clinical Practice (GCP) E6(R3) on 6 January 2025.

The tenants of a social housing unit were required to remove an electric charging station they had installed without the landlord's permission, as the installation, according to the High Court...

In a No Action Letter, EBA provides welcome clarifications regarding the interplay between PSD2 and MiCA for transactions with EMTs but substantial obligations...

In 2024, enforcement actions related to EU sanctions violations increased significantly, marked by new court verdicts in the Netherlands, Latvia, Hungary, and Germany.

The Data Act (Regulation (EU) 2023/2854) will apply from 12 September 2025 and it introduces significant obligations for companies that manufacture IoT devices or provide digital services or cloud services.

EU operators are required to "undertake their best efforts" to ensure that their subsidiaries (including those in Russia) do not participate in activities undermining the restrictive measures provided.

On 24 October 2024, the European Court of Justice ("ECJ") delivered a landmark ruling in Case C-240/22 P (Intel), bringing an end to the long-running legal dispute between Intel and the European Commission (the "Commission").

On 21 February 2025, the Danish Supreme Court ruled on whether two employees were entitled to retain their unvested stock options and restricted stock units (RSUs) following employer-initiated terminations.

On 21 March 2025, the Danish Medicines Agency published an analysis examining the potential advantages and disadvantages of introducing generic prescribing in Denmark.

On 4 June 2025, the Council of the European Union adopted its general approach to the proposed reform of the EU pharmaceutical legislation (the Pharma Package).

The European Commission has launched a public consultation on draft revisions of the Technology Transfer Block Exemption Regulation and the accompanying Guidelines.

The European Commission has just launched an open call for evidence to help shape discussions on a new life sciences strategy for Europe.

The new reform of EU's design legislation, which was published on 18 November 2024 and entered into force on 8 December 2024, preserves the existing dual structure by introducing a new European Design Regulation...

On 11 March 2025, the European Commission presented its proposal for a Critical Medicines Act ("CMA").